[{"address1": "3530 John Hopkins Court", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "844 696 5235", "website": "https://immunitybio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-gu\u00e9rin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.", "fullTimeEmployees": 673, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc.", "age": 72, "title": "Executive Chairman of the Board and Global Chief Scientific & Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 1012368, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard Gerald Adcock", "age": 56, "title": "President, CEO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1343767, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David C. Sachs", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 818647, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barry J. Simon M.D.", "age": 60, "title": "Chief Corporate Affairs Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Regan J. Lauer", "age": 55, "title": "Chief Accounting Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Enrique  Dilon\u00e9 Ph.D., RAC", "age": 58, "title": "Chief Technology Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Singleton", "title": "Chief Communications Officer & Head of Patient Advocacy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emily  Arison", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Leonard S. Sender M.D.", "title": "Chief Medical Officer of Liquid Tumors & Cell Therapy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sandeep K. Reddy M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.61, "open": 8.63, "dayLow": 8.32, "dayHigh": 9.25, "regularMarketPreviousClose": 8.61, "regularMarketOpen": 8.63, "regularMarketDayLow": 8.32, "regularMarketDayHigh": 9.25, "payoutRatio": 0.0, "beta": 0.017, "forwardPE": -33.895664, "volume": 45032269, "regularMarketVolume": 45032269, "averageVolume": 27630576, "averageVolume10days": 22028760, "averageDailyVolume10Day": 22028760, "bid": 8.66, "ask": 8.73, "bidSize": 54, "askSize": 110, "marketCap": 8569197056, "fiftyTwoWeekLow": 1.83, "fiftyTwoWeekHigh": 9.25, "allTimeHigh": 45.42, "allTimeLow": 0.93, "priceToSalesTrailing12Months": 103.79986, "fiftyDayAverage": 3.8925, "twoHundredDayAverage": 2.87075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9173581824, "profitMargins": 0.0, "floatShares": 336168616, "sharesOutstanding": 984965179, "sharesShort": 135160945, "sharesShortPriorMonth": 120642502, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1372, "heldPercentInsiders": 0.66449, "heldPercentInstitutions": 0.17563999, "shortRatio": 2.79, "shortPercentOfFloat": 0.4085, "impliedSharesOutstanding": 984965179, "bookValue": -0.532, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -348616000, "trailingEps": -0.41, "forwardEps": -0.25667, "enterpriseToRevenue": 111.121, "enterpriseToEbitda": -37.451, "52WeekChange": 0.77462685, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 8.7, "targetHighPrice": 24.0, "targetLowPrice": 7.0, "targetMeanPrice": 11.8, "targetMedianPrice": 9.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 257812992, "totalCashPerShare": 0.262, "ebitda": -244947008, "totalDebt": 861289024, "quickRatio": 5.103, "currentRatio": 5.767, "totalRevenue": 82555000, "revenuePerShare": 0.096, "returnOnAssets": -0.36889, "grossProfits": 82184000, "freeCashflow": -230464496, "operatingCashflow": -319702016, "revenueGrowth": 4.251, "grossMargins": 0.99551004, "ebitdaMargins": -2.96708, "operatingMargins": -1.73513, "financialCurrency": "USD", "symbol": "IBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsCurrentYear": -0.40333, "priceEpsCurrentYear": -21.570425, "fiftyDayAverageChange": 4.8075, "fiftyDayAverageChangePercent": 1.2350675, "twoHundredDayAverageChange": 5.82925, "twoHundredDayAverageChangePercent": 2.030567, "priceToBook": -16.353382, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1438090200000, "postMarketChangePercent": -0.017242871, "postMarketPrice": 8.6985, "postMarketChange": -0.0015001297, "regularMarketChange": 0.0900002, "regularMarketDayRange": "8.32 - 9.25", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 27630576, "fiftyTwoWeekLowChange": 6.87, "fiftyTwoWeekLowChangePercent": 3.7540982, "fiftyTwoWeekRange": "1.83 - 9.25", "fiftyTwoWeekHighChange": -0.5500002, "fiftyTwoWeekHighChangePercent": -0.05945948, "fiftyTwoWeekChangePercent": 77.462685, "shortName": "ImmunityBio, Inc.", "longName": "ImmunityBio, Inc.", "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_303022599", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.0453, "regularMarketPrice": 8.7, "corporateActions": [], "postMarketTime": 1771635595, "regularMarketTime": 1771621201, "earningsTimestampStart": 1772485200, "earningsTimestampEnd": 1772485200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.41, "epsForward": -0.25667, "displayName": "ImmunityBio", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]